Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Clin Infect Dis ; 33(6): 901-5, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11512097

ABSTRACT

We report the development of Campylobacter jejuni enteritis in a patient with preexisting humoral and cellular immune recognition of C. jejuni antigens. This is one of few studies in which the immunologic status of a person with regard to C. jejuni before and after C. jejuni infection is directly compared, and it is the only study of which we are aware that includes measurements of cellular immunity. The findings may be important to Campylobacter vaccine development efforts.


Subject(s)
Campylobacter Infections/immunology , Campylobacter jejuni , Enteritis/immunology , Antibodies, Bacterial/blood , Antigens, Bacterial , Campylobacter Infections/etiology , Campylobacter jejuni/immunology , Humans , Immunity, Cellular , Immunoglobulin A/blood , Immunoglobulin G/blood , Male , Middle Aged
2.
J Pediatr Gastroenterol Nutr ; 32(2): 189-96, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11321391

ABSTRACT

BACKGROUND: In the developing world, children are often observed to have both diarrhea and malnutrition. This observation has led many researchers to speculate that diarrhea may produce malnutrition and that malnutrition may predispose to diarrhea. In this study, the interrelationship between diarrhea and malnutrition was investigated among 143 Egyptian children less than 3 years of age. METHODS: For 22 months, children were followed for diarrhea at twice weekly home visits and measured for nutritional status at approximately 3-month intervals. Nutritional measurements were converted to z-scores based on the National Center for Health Statistics/World Health Organization (NCHS/WHO) reference population. RESULTS: Three hundred fifty-eight diarrheal episodes were reported with only 1% of episodes lasting 14 days or more. Stunting, wasting, and low weight-for-age were found in 19%, 3%, and 7%, of these children, respectively. When testing whether malnutrition predisposes to diarrhea, a weight-for-age z-score of <-2 standard deviations was associated with increased incidence of diarrhea (RR = 1.7, P < 0.01) but not height-for-age or weight-for-height. Diarrhea itself was associated with a subsequent attack of diarrhea (RR = 2.1, P < 0.001). During short intervals of follow-up (approximately 3 months), an association was detected between diarrhea episodes and growth faltering for height-for-age z-score (-0.16, P < 0.05). This association was reduced, however, when analyzed during 6-month intervals, if no diarrhea was reported in either the first or second half of this interval. CONCLUSIONS: In a population with moderate malnutrition, both low weight-for-age and diarrhea itself are associated with increased diarrhea risk. Diarrhea alone does not appear to contribute substantially to malnutrition when children have diarrhea-free time for catch-up growth.


Subject(s)
Child Nutrition Disorders/etiology , Diarrhea/etiology , Infant Nutrition Disorders/etiology , Nutritional Status , Body Height , Body Weight , Child Nutrition Disorders/prevention & control , Child, Preschool , Diarrhea/prevention & control , Egypt , Female , Growth , Humans , Incidence , Infant , Infant Nutrition Disorders/prevention & control , Longitudinal Studies , Male , Risk Factors , Urban Health
3.
J Infect Dis ; 179(2): 382-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9878022

ABSTRACT

Enterotoxigenic Escherichia coli (ETEC) are diverse pathogens that express heat-labile (LT) and/or heat-stable (ST) enterotoxins, yet little is known about whether epidemiologic patterns of pediatric ETEC diarrhea vary by the expressed ETEC toxin phenotype. In total, 242 Egyptian children aged <3 years were prospectively followed in 1993-1995. ETEC episodes were detected during twice-weekly home visits, and asymptomatic ETEC excretion was identified from monthly cross-sectional surveys. ETEC episodes were 0.6 per child-year. ST-only ETEC was 2.6 times (P<.001) more common in warmer than cooler months, while LT-only ETEC showed no seasonal variation. Ownership of a household sanitary latrine, but not breast-feeding, was associated with a lower risk of both enterotoxin phenotypes. Coexpression of a colonization factor by LT- or ST-only ETEC strengthened the association with diarrhea. These findings indicate that the epidemiologic patterns of LT-only and ST-only ETEC are not identical and that disease interventions should include improved household sanitation.


Subject(s)
Diarrhea, Infantile/epidemiology , Escherichia coli Infections/epidemiology , Escherichia coli/pathogenicity , Cohort Studies , Diarrhea, Infantile/microbiology , Egypt/epidemiology , Escherichia coli Infections/microbiology , Humans , Incidence , Infant , Infant, Newborn , Prospective Studies , Urban Population , Virulence
4.
Clin Diagn Lab Immunol ; 4(3): 375-9, 1997 May.
Article in English | MEDLINE | ID: mdl-9144380

ABSTRACT

A sensitive, and at times the most sensitive, measurement of human vaccine immunogenicity is enumeration of antibody-secreting cells (ASC) in peripheral blood. However, this assay, which is inherently capable of measurement of the absolute number of antigen-specific ASC, is not standardized. Thus, quantitative comparison of results between laboratories is not currently possible. To address this issue, isotype-specific ASC were enumerated from paired fresh and cryopreserved mononuclear cell (MNC) preparations from healthy adult volunteers resident in either the United States (US group) or Egypt (EG group). Analysis of fresh cells from US volunteers revealed mean numbers of ASC per 10(6) MNC of 617, 7,738, and 868 for immunoglobulin M (IgM), IgG, and IgA, respectively, whereas EG volunteers had 2,086, 7,580, and 1,677 ASC/10(6) MNC for the respective isotypes. Cryopreservation resulted in a slight reduction in group mean IgM, IgG, and IgA ASC (maximum reduction in group mean, 14%), but in no instance were results obtained with cryopreserved cells significantly lower than those obtained with fresh cells. To determine if cryopreservation affected the number of bacterial antigen-specific ASC detected, cells from a group of US adult volunteers who received a single oral dose of a mutated Escherichia coli heat-labile enterotoxin (LT(R192G)) were tested. There was no significant difference (P > 0.05) in the number of antigen-specific IgA or IgG ASC detected between fresh and cryopreserved MNC. The results support the views that ASC assays can be standardized to yield quantitative results and that the methodology can be changed to make the test more practical.


Subject(s)
Antibody-Producing Cells/immunology , Escherichia coli Proteins , Immunoglobulins/biosynthesis , Lymphocyte Count/methods , Adult , Antibodies, Bacterial/biosynthesis , Antigens, Bacterial , Bacterial Toxins/immunology , Blood Preservation , Cryopreservation , Enterotoxins/immunology , Escherichia coli/immunology , Female , Humans , Immunoglobulin Isotypes/biosynthesis , Male , Middle Aged
5.
Infect Immun ; 64(12): 4933-9, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8945529

ABSTRACT

Campylobacter jejuni infection of mice initiated by intranasal administration was investigated as a potential model for studies of pathogenesis and immunity. By using a standard challenge (5 x 10(9) CFU), C. jejuni 81-176 was more virulent for BALB/c (72% mortality) than for C3H/Hej (50%), CBA/CAJ (30%), or C58/J (0%). Intranasal challenge of BALB/c was used to compare the relative virulence of three reference strains; C.jejuni 81-176 was more virulent (killing 83% of challenged mice) than C. jejuni HC (0%) or C. coli VC-167 (0%). The course of intranasally initiated C. jejuni 81-176 infection in BALB/c was determined. C. jejuni was recovered from the lungs, intestinal tract, liver, and spleen at 4 h after challenge, the first interval evaluated. After this initial interval, three distinct patterns of infection were recognized: (i) a progressive decline in number of C. jejuni CFU (stomach, blood, lungs), (ii) decline followed by a second peak in the number of organisms recovered at 2 or 3 days postchallenge (intestine, liver, mesenteric lymph nodes), and (iii) persistence of approximately the same number of C.jejuni CFU during the course of the experiment (spleen). Intranasally induced infection initiated with a sublethal number of bacteria or intranasal immunization with killed Campylobacter preparations resulted in both the generation of Campylobacter antigen-specific immune responses and an acquired resistance to homologous rechallenge. The model was used to evaluate the relative virulence of nine low-in vitro-passage (no more than five passages) isolates of C. jejuni species from patients with diarrhea. The patient isolates were differentially virulent for mice; one killed all exposed mice, three were avirulent (no deaths) and the remainder showed an intermediate virulence, killing 17 to 33%. Mouse virulence of Campylobacter strains showed a trend toward isolates originating from individuals with watery diarrhea; however, no association was found between mouse virulence and other signs or symptoms. There were no observed relationships between mouse virulence and bacterial Lior serotype or Fla polymorphic group. Intranasal challenge of BALB/c with C. jejuni is a useful model for the study of infection and vaccination-acquired immunity to this agent.


Subject(s)
Campylobacter Infections , Campylobacter jejuni , Animals , Campylobacter Infections/immunology , Campylobacter Infections/physiopathology , Campylobacter jejuni/pathogenicity , Disease Models, Animal , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred CBA , Virulence
6.
J Egypt Public Health Assoc ; 71(3-4): 213-28, 1996.
Article in English | MEDLINE | ID: mdl-17217009

ABSTRACT

Hantaan virus has recently been identified as the cause of the rodent borne viral zoonosis collectively termed Hantavirus disease (HVD). Although the disease is mainly endemic in two main areas, clinical forms as well as positive antibody testing from healthy persons throughout the world have been reported denoting a worldwide presence. Rattus species are almost universally implicated as hantavirus reservoirs. Screening for hantavirus antibodies was done on 637 samples of human sera and 861 rodent sera trapped from 26 locations throughout the city of Alexandria, Egypt. ELISA assays were performed and 12.2% of humans were found seropositive with no effect of age, duration of work at sea or residence on seropositivity. 12.8% of rodents were seropositive with Rattus norvegicus showing the highest prevalence and with no influence of sex, age or habitat. A significant association was found between the east district and seropositivity to Hantaan in rodents.


Subject(s)
Hantavirus Infections/epidemiology , Hantavirus Infections/veterinary , Rats , Rodent Diseases/epidemiology , Urban Health/statistics & numerical data , Zoonoses/epidemiology , Adolescent , Adult , Aged , Animals , Disease Vectors , Egypt/epidemiology , Endemic Diseases/statistics & numerical data , Enzyme-Linked Immunosorbent Assay , Hantavirus Infections/blood , Hantavirus Infections/transmission , Humans , Mass Screening , Middle Aged , Naval Medicine , Occupational Diseases/epidemiology , Population Surveillance , Prisoners , Residence Characteristics/statistics & numerical data , Rodent Diseases/blood , Rodent Diseases/transmission , Seroepidemiologic Studies , Zoonoses/transmission
7.
Eur J Gastroenterol Hepatol ; 7(9): 871-5, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8574720

ABSTRACT

OBJECTIVE: To compare zaldaride maleate, a calmodulin inhibitor with gastrointestinal antisecretory properties, with loperamide and a placebo in the treatment of travellers' diarrhoea. DESIGN: Randomized, double-blind, double-dummy study. SETTING: Study clinic staffed by European residents on Nile cruise ships. PATIENTS: Tourists (n = 436) who acquired travellers' diarrhoea during the Nile cruise. INTERVENTIONS: (1) Zaldaride 20 mg four times daily, (2) zaldaride 2 x 20 mg as initial loading dose followed by three doses of 20 mg on the first day and four doses of 20 mg on the second day, (3) loperamide 2 x 2 mg loading dose following by a flexible dosage of 2 mg after each unformed stool (maximum of 16 mg daily), (4) placebo. MAIN OUTCOME MEASURES: Number of unformed stools, rate of improvement of patients with diarrhoea, rate of relief from diarrhoea. RESULTS: Among the 331 compliant and fully evaluated patients, the zaldaride with loading dose group showed no significant differences in cure rates from the loperamide group. For most parameters, zaldaride without a loading dose and the placebo resulted in significantly lower cure rates. CONCLUSIONS: A zaldaride regimen including a loading dose was shown to be well tolerated and as effective as loperamide.


Subject(s)
Antidiarrheals/administration & dosage , Benzimidazoles/administration & dosage , Diarrhea/drug therapy , Loperamide/administration & dosage , Travel , Adolescent , Adult , Aged , Antidiarrheals/therapeutic use , Benzimidazoles/therapeutic use , Double-Blind Method , Drug Administration Schedule , Female , Humans , Loperamide/therapeutic use , Male , Middle Aged , Treatment Outcome
8.
J Egypt Public Health Assoc ; 70(3-4): 229-41, 1995.
Article in English | MEDLINE | ID: mdl-17214155

ABSTRACT

The role of Campylobacter as a cause of bacterial diarrhea in young children in Alexandria, Egypt was investigated. Stools or rectal swabs were collected from 880 children (mean age 9.8 months) presenting to a hospital with the primary complaint of diarrhea and from 1,079 well children (mean age 8.8 months) attending a vaccination clinic. Isolation of Campylobacter was significantly (p<0.0002) more frequent from cases (17.2%) than from controls (6.4%). Campylobacter was isolated from children presenting with diarrhea more frequently than Salmonella (3% isolation rate), Shigella (2% isolation rate), or other bacterial pathogens (1% isolatoin rate). Isolation of Campylobacter was significantly more frequent during the rainy season (p<0.0012). These results implicate Campylobacter as a major bacterial cause of diarrhea for which young children are brought for medical attention in Alexandria, Egypt.


Subject(s)
Campylobacter Infections , Diarrhea , Urban Health/statistics & numerical data , Ambulatory Care Facilities , Animals , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Case-Control Studies , Causality , Child , Child Welfare/statistics & numerical data , Child, Preschool , Diarrhea/epidemiology , Diarrhea/microbiology , Dysentery, Bacillary/epidemiology , Egypt/epidemiology , Feces/microbiology , Humans , Infant , Infant, Newborn , Population Surveillance , Poultry/microbiology , Salmonella Infections/epidemiology , Seasons , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...